

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen processing and presentation (GO:0002579) | 9.54358004 |
| 2 | fusion of sperm to egg plasma membrane (GO:0007342) | 8.74658222 |
| 3 | regulation of acrosome reaction (GO:0060046) | 8.01649482 |
| 4 | seminiferous tubule development (GO:0072520) | 7.76272545 |
| 5 | regulation of antigen processing and presentation (GO:0002577) | 7.75959007 |
| 6 | plasma membrane fusion (GO:0045026) | 6.66345358 |
| 7 | regulation of clathrin-mediated endocytosis (GO:2000369) | 6.24309251 |
| 8 | complement activation, alternative pathway (GO:0006957) | 5.68930271 |
| 9 | regulation of T cell tolerance induction (GO:0002664) | 5.38244815 |
| 10 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.36668548 |
| 11 | kynurenine metabolic process (GO:0070189) | 4.99042303 |
| 12 | positive regulation of tolerance induction (GO:0002645) | 4.40486516 |
| 13 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 4.06071670 |
| 14 | sperm capacitation (GO:0048240) | 3.95907282 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 3.91282877 |
| 16 | tryptophan catabolic process (GO:0006569) | 3.91282877 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.91282877 |
| 18 | regulation of tolerance induction (GO:0002643) | 3.88726197 |
| 19 | eye photoreceptor cell differentiation (GO:0001754) | 3.82112500 |
| 20 | photoreceptor cell differentiation (GO:0046530) | 3.82112500 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 3.81719548 |
| 22 | response to nitrosative stress (GO:0051409) | 3.77399058 |
| 23 | macroautophagy (GO:0016236) | 3.61699772 |
| 24 | tryptophan metabolic process (GO:0006568) | 3.54246227 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49189383 |
| 26 | regulation of chronic inflammatory response (GO:0002676) | 3.48321974 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 3.46756126 |
| 28 | negative regulation of interleukin-10 production (GO:0032693) | 3.43853833 |
| 29 | valine metabolic process (GO:0006573) | 3.41625216 |
| 30 | growth hormone receptor signaling pathway (GO:0060396) | 3.28317393 |
| 31 | benzene-containing compound metabolic process (GO:0042537) | 3.26206760 |
| 32 | negative regulation of endopeptidase activity (GO:0010951) | 3.17445109 |
| 33 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.14333986 |
| 34 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.12574684 |
| 35 | sexual reproduction (GO:0019953) | 3.11870437 |
| 36 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.11567002 |
| 37 | regulation of complement activation (GO:0030449) | 3.10162583 |
| 38 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.07256923 |
| 39 | keratan sulfate catabolic process (GO:0042340) | 3.05033082 |
| 40 | negative regulation of peptidase activity (GO:0010466) | 3.03284123 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 2.99842315 |
| 42 | regulation of protein activation cascade (GO:2000257) | 2.98828574 |
| 43 | response to misfolded protein (GO:0051788) | 2.96458869 |
| 44 | cellular sodium ion homeostasis (GO:0006883) | 2.85329856 |
| 45 | xenobiotic catabolic process (GO:0042178) | 2.82018445 |
| 46 | aromatic amino acid family catabolic process (GO:0009074) | 2.79422302 |
| 47 | cellular response to growth hormone stimulus (GO:0071378) | 2.77084858 |
| 48 | mannose metabolic process (GO:0006013) | 2.73298633 |
| 49 | phospholipid homeostasis (GO:0055091) | 2.73094270 |
| 50 | negative regulation of protein autophosphorylation (GO:0031953) | 2.69726386 |
| 51 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.68440206 |
| 52 | heterotypic cell-cell adhesion (GO:0034113) | 2.67267490 |
| 53 | hypotonic response (GO:0006971) | 2.64406083 |
| 54 | cytolysis (GO:0019835) | 2.62135400 |
| 55 | single fertilization (GO:0007338) | 2.61681880 |
| 56 | reverse cholesterol transport (GO:0043691) | 2.57479409 |
| 57 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.56223676 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.48840562 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 2.47221703 |
| 60 | amine catabolic process (GO:0009310) | 2.47221703 |
| 61 | respiratory burst (GO:0045730) | 2.45905647 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 2.45156282 |
| 63 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.44688486 |
| 64 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.44183615 |
| 65 | cysteine metabolic process (GO:0006534) | 2.42037005 |
| 66 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.39711966 |
| 67 | negative regulation of interleukin-8 production (GO:0032717) | 2.30293174 |
| 68 | linoleic acid metabolic process (GO:0043651) | 2.29932748 |
| 69 | striated muscle atrophy (GO:0014891) | 2.29337948 |
| 70 | natural killer cell mediated immunity (GO:0002228) | 2.27439180 |
| 71 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.27439180 |
| 72 | nucleoside diphosphate catabolic process (GO:0009134) | 2.25370738 |
| 73 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.24389099 |
| 74 | high-density lipoprotein particle remodeling (GO:0034375) | 2.22706383 |
| 75 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.22207157 |
| 76 | nerve growth factor signaling pathway (GO:0038180) | 2.13665477 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 2.13584791 |
| 78 | ethanol oxidation (GO:0006069) | 2.11957548 |
| 79 | regulation of lipoprotein metabolic process (GO:0050746) | 2.11012689 |
| 80 | cellular response to interferon-alpha (GO:0035457) | 2.10178129 |
| 81 | negative regulation of T cell apoptotic process (GO:0070233) | 2.07169764 |
| 82 | complement activation (GO:0006956) | 2.02676310 |
| 83 | myeloid cell homeostasis (GO:0002262) | 2.01194609 |
| 84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 18.7748086 |
| 85 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 18.7748086 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 17.8979992 |
| 87 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 17.3670151 |
| 88 | antigen processing and presentation of endogenous antigen (GO:0019883) | 15.8677217 |
| 89 | regulation of humoral immune response (GO:0002920) | 1.98821583 |
| 90 | response to hydroperoxide (GO:0033194) | 1.98381787 |
| 91 | negative regulation of proteolysis (GO:0045861) | 1.98073567 |
| 92 | sulfur compound catabolic process (GO:0044273) | 1.97422643 |
| 93 | skeletal muscle adaptation (GO:0043501) | 1.96673674 |
| 94 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 1.95840475 |
| 95 | fibroblast migration (GO:0010761) | 1.95724040 |
| 96 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 1.95642156 |
| 97 | negative regulation of endocytosis (GO:0045806) | 1.93735943 |
| 98 | GPI anchor biosynthetic process (GO:0006506) | 1.92994979 |
| 99 | T-helper 1 type immune response (GO:0042088) | 1.92337346 |
| 100 | positive regulation of cholesterol transport (GO:0032376) | 1.92190659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.37453819 |
| 2 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.81504100 |
| 3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.60220533 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.58311670 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.51419436 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.28539204 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17788210 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.17063495 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.09291058 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.08588463 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 11.6594530 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.98916294 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98346862 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88728311 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77392982 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73499126 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65910900 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.64651298 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60807351 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60579019 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53069180 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47191343 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.46425041 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45408804 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.40500517 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39433210 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39327697 |
| 28 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.34664444 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27811094 |
| 30 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27697562 |
| 31 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27128614 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25370100 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22608307 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22430070 |
| 35 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20044348 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19147484 |
| 37 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.18417982 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15338333 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13158285 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11668898 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10802644 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.08542397 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07960202 |
| 44 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07643655 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07235195 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06527674 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06034034 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01733057 |
| 49 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99572018 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99517025 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98512700 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96849115 |
| 53 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95298567 |
| 54 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93634057 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.93017702 |
| 56 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92835276 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92315772 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92251962 |
| 59 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90818915 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90355294 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89958362 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86882095 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86839766 |
| 64 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85365901 |
| 65 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85035939 |
| 66 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84630520 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.84532243 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.83992424 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83533790 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83425652 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83237895 |
| 72 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.82690115 |
| 73 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80807496 |
| 74 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80430691 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80430691 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80351961 |
| 77 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.80071274 |
| 78 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79287458 |
| 79 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.78628387 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78224856 |
| 81 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78146203 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77866452 |
| 83 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76868618 |
| 84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76809539 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76200458 |
| 86 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76106559 |
| 87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.75406634 |
| 88 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.75115100 |
| 89 | KDM2B_26808549_Chip-Seq_REH_Human | 0.73490325 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73417454 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73417454 |
| 92 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.73391335 |
| 93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.72735445 |
| 94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72563333 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72262747 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.71609948 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71081400 |
| 98 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.70507286 |
| 99 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.69369961 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.69238359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.45996191 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.35152464 |
| 3 | MP0003300_gastrointestinal_ulcer | 4.20475539 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.54147369 |
| 5 | MP0003195_calcinosis | 3.07732885 |
| 6 | MP0005410_abnormal_fertilization | 2.71842699 |
| 7 | MP0002254_reproductive_system_inflammat | 2.66919546 |
| 8 | MP0003303_peritoneal_inflammation | 2.54540463 |
| 9 | MP0005275_abnormal_skin_tensile | 2.41825827 |
| 10 | MP0003436_decreased_susceptibility_to | 2.35619305 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.28579003 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 2.27583302 |
| 13 | MP0003878_abnormal_ear_physiology | 2.27583302 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.24253410 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.15706530 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.14309997 |
| 17 | MP0003045_fibrosis | 2.09579081 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.96655160 |
| 19 | MP0009763_increased_sensitivity_to | 1.89249155 |
| 20 | MP0001533_abnormal_skeleton_physiology | 1.83239293 |
| 21 | MP0000685_abnormal_immune_system | 1.69228564 |
| 22 | MP0010329_abnormal_lipoprotein_level | 1.63900868 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.62030634 |
| 24 | MP0003075_altered_response_to | 1.60489893 |
| 25 | MP0010678_abnormal_skin_adnexa | 1.53488202 |
| 26 | MP0000569_abnormal_digit_pigmentation | 1.51708467 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.51282165 |
| 28 | MP0003091_abnormal_cell_migration | 1.50924031 |
| 29 | MP0004043_abnormal_pH_regulation | 1.49782775 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.48663688 |
| 31 | MP0002168_other_aberrant_phenotype | 1.47541886 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.46915203 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.39940729 |
| 34 | MP0004947_skin_inflammation | 1.38649376 |
| 35 | MP0002282_abnormal_trachea_morphology | 1.38361698 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.36676462 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.36416686 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.26870201 |
| 39 | MP0002006_tumorigenesis | 1.25614287 |
| 40 | MP0004858_abnormal_nervous_system | 1.23559160 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.22167432 |
| 42 | MP0009785_altered_susceptibility_to | 1.20270490 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.19299918 |
| 44 | MP0008995_early_reproductive_senescence | 1.16900503 |
| 45 | MP0005365_abnormal_bile_salt | 1.16564565 |
| 46 | MP0001765_abnormal_ion_homeostasis | 1.16231060 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.15897153 |
| 48 | MP0002896_abnormal_bone_mineralization | 1.14295940 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13025033 |
| 50 | MP0004272_abnormal_basement_membrane | 1.12102829 |
| 51 | MP0005085_abnormal_gallbladder_physiolo | 1.11000232 |
| 52 | MP0002933_joint_inflammation | 1.09959467 |
| 53 | MP0002009_preneoplasia | 1.09738441 |
| 54 | MP0000003_abnormal_adipose_tissue | 1.08186629 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 1.01832761 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.01252971 |
| 57 | MP0003690_abnormal_glial_cell | 1.00468228 |
| 58 | MP0005310_abnormal_salivary_gland | 1.00309490 |
| 59 | MP0005464_abnormal_platelet_physiology | 0.98896022 |
| 60 | MP0001853_heart_inflammation | 0.98691607 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 0.97738754 |
| 62 | MP0003448_altered_tumor_morphology | 0.97175793 |
| 63 | MP0001348_abnormal_lacrimal_gland | 0.96473162 |
| 64 | MP0005375_adipose_tissue_phenotype | 0.93169312 |
| 65 | MP0002419_abnormal_innate_immunity | 0.92771673 |
| 66 | MP0000343_altered_response_to | 0.92324536 |
| 67 | MP0001666_abnormal_nutrient_absorption | 0.92049796 |
| 68 | MP0001881_abnormal_mammary_gland | 0.91929252 |
| 69 | MP0005408_hypopigmentation | 0.91540775 |
| 70 | MP0002693_abnormal_pancreas_physiology | 0.90480668 |
| 71 | MP0000604_amyloidosis | 0.90358540 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 0.89957801 |
| 73 | MP0003252_abnormal_bile_duct | 0.89918556 |
| 74 | MP0005503_abnormal_tendon_morphology | 0.88717085 |
| 75 | MP0001849_ear_inflammation | 0.87052683 |
| 76 | MP0005166_decreased_susceptibility_to | 0.85834637 |
| 77 | MP0006082_CNS_inflammation | 0.85700025 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.85285611 |
| 79 | MP0008004_abnormal_stomach_pH | 0.83816785 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 0.83403312 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.82919018 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.82708453 |
| 83 | MP0005025_abnormal_response_to | 0.82648970 |
| 84 | MP0003329_amyloid_beta_deposits | 0.82579394 |
| 85 | MP0005360_urolithiasis | 0.82317088 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.82110193 |
| 87 | MP0000249_abnormal_blood_vessel | 0.79947415 |
| 88 | MP0003698_abnormal_male_reproductive | 0.79230183 |
| 89 | MP0002796_impaired_skin_barrier | 0.78398995 |
| 90 | MP0005390_skeleton_phenotype | 0.77983416 |
| 91 | MP0003866_abnormal_defecation | 0.77572677 |
| 92 | MP0000609_abnormal_liver_physiology | 0.77547762 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.75893478 |
| 94 | MP0004130_abnormal_muscle_cell | 0.75520324 |
| 95 | MP0003186_abnormal_redox_activity | 0.74408916 |
| 96 | MP0008469_abnormal_protein_level | 0.74320746 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.74125077 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.71884068 |
| 99 | MP0005332_abnormal_amino_acid | 0.70768697 |
| 100 | MP0004134_abnormal_chest_morphology | 0.70138103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 5.88434642 |
| 2 | Abnormality of complement system (HP:0005339) | 5.03541630 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.00553964 |
| 4 | Cervical subluxation (HP:0003308) | 4.75170869 |
| 5 | Myocardial infarction (HP:0001658) | 4.43881417 |
| 6 | Facial shape deformation (HP:0011334) | 4.27067280 |
| 7 | Potter facies (HP:0002009) | 4.27067280 |
| 8 | Choroideremia (HP:0001139) | 4.26772270 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.21932774 |
| 10 | Vascular calcification (HP:0004934) | 3.92239414 |
| 11 | Hand muscle atrophy (HP:0009130) | 3.89315160 |
| 12 | Ulnar deviation of the wrist (HP:0003049) | 3.88258846 |
| 13 | Abnormality of the fovea (HP:0000493) | 3.75206174 |
| 14 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.74146806 |
| 15 | Cardiovascular calcification (HP:0011915) | 3.69290201 |
| 16 | Central scotoma (HP:0000603) | 3.68519377 |
| 17 | 11 pairs of ribs (HP:0000878) | 3.64252710 |
| 18 | Metaphyseal cupping (HP:0003021) | 3.55513409 |
| 19 | Proximal tubulopathy (HP:0000114) | 3.51980526 |
| 20 | Cone-rod dystrophy (HP:0000548) | 3.50280358 |
| 21 | Stridor (HP:0010307) | 3.42998179 |
| 22 | Loss of speech (HP:0002371) | 3.31392529 |
| 23 | Abnormality of macular pigmentation (HP:0008002) | 3.26456242 |
| 24 | Epiphyseal dysplasia (HP:0002656) | 3.19908884 |
| 25 | Upper limb amyotrophy (HP:0009129) | 3.18387083 |
| 26 | Distal upper limb amyotrophy (HP:0007149) | 3.18387083 |
| 27 | Hypophosphatemic rickets (HP:0004912) | 3.16873268 |
| 28 | Hypopigmentation of the fundus (HP:0007894) | 3.10265284 |
| 29 | Diaphragmatic weakness (HP:0009113) | 2.99626728 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.96549764 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.96549764 |
| 32 | Hypoplasia of the odontoid process (HP:0003311) | 2.95797344 |
| 33 | Disproportionate short-trunk short stature (HP:0003521) | 2.93530097 |
| 34 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.88156561 |
| 35 | Intention tremor (HP:0002080) | 2.85469786 |
| 36 | Tubulointerstitial fibrosis (HP:0005576) | 2.76539800 |
| 37 | Dyschromatopsia (HP:0007641) | 2.74616280 |
| 38 | Osteomalacia (HP:0002749) | 2.69766498 |
| 39 | Spontaneous abortion (HP:0005268) | 2.69261317 |
| 40 | Progressive visual loss (HP:0000529) | 2.66079544 |
| 41 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.59421658 |
| 42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.59421658 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.59421658 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.58522480 |
| 45 | Agitation (HP:0000713) | 2.58178781 |
| 46 | Action tremor (HP:0002345) | 2.57649612 |
| 47 | Mutism (HP:0002300) | 2.52457395 |
| 48 | Macular degeneration (HP:0000608) | 2.51911338 |
| 49 | Muscle fiber splitting (HP:0003555) | 2.50801906 |
| 50 | Abnormality of the odontoid process (HP:0003310) | 2.49310492 |
| 51 | Flat acetabular roof (HP:0003180) | 2.42066707 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.39567058 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39567058 |
| 54 | Delayed epiphyseal ossification (HP:0002663) | 2.31265984 |
| 55 | Facial diplegia (HP:0001349) | 2.28787888 |
| 56 | Ectopia lentis (HP:0001083) | 2.27161033 |
| 57 | Missing ribs (HP:0000921) | 2.25755167 |
| 58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.23568380 |
| 59 | Hyperphosphatemia (HP:0002905) | 2.20578635 |
| 60 | Abnormality of the calcaneus (HP:0008364) | 2.19634905 |
| 61 | Infantile muscular hypotonia (HP:0008947) | 2.19353008 |
| 62 | Duplicated collecting system (HP:0000081) | 2.14383956 |
| 63 | Thin bony cortex (HP:0002753) | 2.10628868 |
| 64 | Restlessness (HP:0000711) | 2.08260080 |
| 65 | Eczematoid dermatitis (HP:0000976) | 2.07606131 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.05056694 |
| 67 | Ovoid vertebral bodies (HP:0003300) | 2.03463934 |
| 68 | Clumsiness (HP:0002312) | 2.01745490 |
| 69 | Esophageal varix (HP:0002040) | 2.01461035 |
| 70 | Right ventricular cardiomyopathy (HP:0011663) | 2.00891584 |
| 71 | Abnormality of macrophages (HP:0004311) | 1.98649576 |
| 72 | Decreased central vision (HP:0007663) | 1.94802811 |
| 73 | Impulsivity (HP:0100710) | 1.93983611 |
| 74 | Rickets (HP:0002748) | 1.88275330 |
| 75 | Focal segmental glomerulosclerosis (HP:0000097) | 1.87721081 |
| 76 | Enlarged epiphyses (HP:0010580) | 1.87602074 |
| 77 | Beaking of vertebral bodies (HP:0004568) | 1.86810720 |
| 78 | Bicornuate uterus (HP:0000813) | 1.84257035 |
| 79 | Abnormality of the lumbar spine (HP:0100712) | 1.82794074 |
| 80 | Gingivitis (HP:0000230) | 1.82482659 |
| 81 | Proximal amyotrophy (HP:0007126) | 1.81543616 |
| 82 | Aneurysm (HP:0002617) | 1.81187420 |
| 83 | Scotoma (HP:0000575) | 1.80386342 |
| 84 | Glomerulosclerosis (HP:0000096) | 1.78910375 |
| 85 | Neurofibrillary tangles (HP:0002185) | 1.78397381 |
| 86 | Increased connective tissue (HP:0009025) | 1.76701640 |
| 87 | Abnormality of the vocal cords (HP:0008777) | 1.76681690 |
| 88 | Aplasia of the musculature (HP:0100854) | 1.76113582 |
| 89 | Deep venous thrombosis (HP:0002625) | 1.75664612 |
| 90 | Thin ribs (HP:0000883) | 1.74107112 |
| 91 | Metaphyseal irregularity (HP:0003025) | 1.73892818 |
| 92 | Vitreoretinal degeneration (HP:0000655) | 1.73209079 |
| 93 | Tetraparesis (HP:0002273) | 1.72227671 |
| 94 | Increased IgE level (HP:0003212) | 1.72186755 |
| 95 | Scanning speech (HP:0002168) | 1.71555710 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 1.70456940 |
| 97 | Aortic aneurysm (HP:0004942) | 1.69668678 |
| 98 | Gingival bleeding (HP:0000225) | 1.68984402 |
| 99 | Hypercortisolism (HP:0001578) | 1.68423695 |
| 100 | Barrel-shaped chest (HP:0001552) | 1.68175031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 4.72053690 |
| 2 | EPHA3 | 4.00649303 |
| 3 | MST4 | 3.71627954 |
| 4 | EPHB1 | 3.57775987 |
| 5 | PBK | 2.92611295 |
| 6 | MAP3K9 | 2.76772905 |
| 7 | AKT3 | 2.57369412 |
| 8 | SIK1 | 2.57032041 |
| 9 | TAOK3 | 2.56286834 |
| 10 | FGFR4 | 2.46263292 |
| 11 | FER | 2.23935465 |
| 12 | ARAF | 2.23530585 |
| 13 | MAP3K14 | 2.23487913 |
| 14 | ERN1 | 2.15588613 |
| 15 | LATS1 | 1.98452464 |
| 16 | WNK4 | 1.97752687 |
| 17 | MYLK | 1.93141489 |
| 18 | FRK | 1.84950087 |
| 19 | KSR2 | 1.55639359 |
| 20 | WNK3 | 1.55280794 |
| 21 | JAK1 | 1.53981690 |
| 22 | ERBB3 | 1.53225647 |
| 23 | INSRR | 1.46608796 |
| 24 | LMTK2 | 1.46552522 |
| 25 | DDR2 | 1.42064585 |
| 26 | IRAK1 | 1.41565258 |
| 27 | MAP3K3 | 1.30272529 |
| 28 | TRIB3 | 1.28397503 |
| 29 | NEK9 | 1.20805809 |
| 30 | JAK3 | 1.15870773 |
| 31 | MATK | 1.13987226 |
| 32 | PAK3 | 1.06950990 |
| 33 | TTN | 1.05621610 |
| 34 | FGFR3 | 1.02070050 |
| 35 | TYK2 | 1.00773309 |
| 36 | TNK2 | 1.00597624 |
| 37 | JAK2 | 0.97946263 |
| 38 | PKN2 | 0.95630897 |
| 39 | ERBB2 | 0.95304509 |
| 40 | IRAK3 | 0.94490635 |
| 41 | FGFR2 | 0.92540707 |
| 42 | LRRK2 | 0.90855890 |
| 43 | CAMK1D | 0.90513389 |
| 44 | RET | 0.86310427 |
| 45 | MAP3K1 | 0.85444597 |
| 46 | PTK6 | 0.82985000 |
| 47 | STK39 | 0.81993364 |
| 48 | RIPK4 | 0.81718816 |
| 49 | TBK1 | 0.79521774 |
| 50 | MAP2K1 | 0.75880329 |
| 51 | MAP3K7 | 0.75623350 |
| 52 | MOS | 0.74999747 |
| 53 | WNK1 | 0.74896319 |
| 54 | DAPK2 | 0.73363728 |
| 55 | HIPK2 | 0.72009875 |
| 56 | PTK2 | 0.67177747 |
| 57 | PDGFRA | 0.66896569 |
| 58 | PTK2B | 0.66016231 |
| 59 | PAK2 | 0.65536607 |
| 60 | EGFR | 0.63882842 |
| 61 | MAP3K2 | 0.62951154 |
| 62 | RPS6KA4 | 0.61272577 |
| 63 | ALK | 0.60474350 |
| 64 | DYRK1B | 0.56818111 |
| 65 | MAPKAPK3 | 0.56428405 |
| 66 | TYRO3 | 0.55908661 |
| 67 | NTRK1 | 0.55420563 |
| 68 | STK4 | 0.51884848 |
| 69 | TRPM7 | 0.50208468 |
| 70 | PRKD3 | 0.50072178 |
| 71 | RIPK1 | 0.49364642 |
| 72 | PIK3CG | 0.49127068 |
| 73 | KSR1 | 0.47154472 |
| 74 | SRC | 0.46869393 |
| 75 | RAF1 | 0.46566589 |
| 76 | DAPK3 | 0.44836151 |
| 77 | MAP2K4 | 0.43237756 |
| 78 | FYN | 0.40914029 |
| 79 | BMPR2 | 0.40681268 |
| 80 | INSR | 0.39830261 |
| 81 | STK3 | 0.38946874 |
| 82 | CAMK1G | 0.38415235 |
| 83 | PRKCQ | 0.37605587 |
| 84 | IRAK4 | 0.36328190 |
| 85 | NLK | 0.35629593 |
| 86 | HCK | 0.34235863 |
| 87 | SGK1 | 0.31659829 |
| 88 | MAP2K3 | 0.31594638 |
| 89 | MAPKAPK5 | 0.30841424 |
| 90 | SYK | 0.30765995 |
| 91 | BMX | 0.28110588 |
| 92 | CHUK | 0.26268394 |
| 93 | GSK3A | 0.26093292 |
| 94 | LCK | 0.25960351 |
| 95 | EEF2K | 0.23723407 |
| 96 | MTOR | 0.23088195 |
| 97 | PDPK1 | 0.22374165 |
| 98 | CDK19 | 0.21195228 |
| 99 | TESK1 | 0.20951019 |
| 100 | MAPK12 | 0.20594127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.86003287 |
| 2 | ABC transporters_Homo sapiens_hsa02010 | 3.60476942 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.52128381 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83862022 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.65827586 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39691626 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.29761443 |
| 8 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.28103047 |
| 9 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.13054325 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09015170 |
| 11 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.93589365 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86477637 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78555475 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77676857 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72673560 |
| 16 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.68397209 |
| 17 | Prion diseases_Homo sapiens_hsa05020 | 1.56133944 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.55626127 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.48742891 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.44806776 |
| 21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.42016848 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.41993940 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37736479 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.36538489 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.32502033 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23588048 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.22968325 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22185170 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19368727 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18672090 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17349891 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05649893 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97705712 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 0.97101728 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96829579 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96150464 |
| 37 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95185093 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94398487 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91848404 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91578398 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88880816 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 0.86995522 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.86012888 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85376781 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83905694 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82475484 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81564096 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78304917 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72554191 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70316676 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.68144059 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65711436 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.64272433 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.62508367 |
| 55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59918326 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59661307 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58706020 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58169310 |
| 59 | Legionellosis_Homo sapiens_hsa05134 | 0.57944932 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57880509 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54435890 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54413082 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.53050658 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52778903 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51584031 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51168260 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49879411 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.49386821 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.49324707 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49023959 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48018852 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47969365 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.42284564 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41601086 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39797804 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39517553 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39064853 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.38531528 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37402648 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.37169890 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35969626 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35490880 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34334712 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.34186485 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33017313 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32783657 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32541067 |
| 88 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32159018 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31784797 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31216049 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.30619450 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.30168472 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29540717 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.28965354 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28790838 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28423509 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.28013832 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.27742243 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27704302 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26773921 |

